| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |